Toll-like receptor 9 activation by mitochondrial DNA causes vascular injury in hypertension
线粒体 DNA 激活 Toll 样受体 9 导致高血压血管损伤
基本信息
- 批准号:10094229
- 负责人:
- 金额:$ 38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAdultAffectAgonistAnimalsAntihypertensive AgentsAortaArteriesAttenuatedBedsBiochemicalBiological AvailabilityBloodBlood CirculationBlood PressureBlood VesselsCardiovascular DiseasesCell DeathCellsCerebrumCessation of lifeCharacteristicsClinicalCoronaryCoronary ArteriosclerosisDNADataDevelopmentDisease ManagementEndotheliumEventFailureGenetic ModelsHumanHypertensionImmune systemInbred SHR RatsInflammatoryInjuryInnate Immune ResponseInnate Immune SystemKidneyKidney DiseasesLeadLigationLinkMaintenanceMediatingMesenteryMitochondrial DNAModelingMolecularMuscleMycotoxinsNecrosisNitric OxideOrganPathogenesisPathway interactionsPatientsPatternPattern recognition receptorPharmacologyPhasePhenotypePhysiologicalPlayRattusRelaxationResearchRoleSchemeSignal TransductionStimulusStrokeTLR9 geneTechniquesTestingTissuesVascular DiseasesVascular remodelingVasodilationarterial stiffnessarteriolebaseblood pressure reductioncell injurycytokineendothelial dysfunctionexperimental studyfemoral arteryimmune activationimprovedinhibitor/antagonistkidney vascular structureneuromechanismnew therapeutic targetnormotensivenovelnucleasepressurepreventresponsevascular inflammationvascular injuryvasoconstriction
项目摘要
PROJECT SUMMARY P1, WEBB
Toll-like receptor 9 activation by mitochondrial DNA causes vascular injury in hypertension
Hypertension affects over 75 million U.S. adults and plays a major role in the end organ damage commonly
seen with cardiovascular diseases, including stroke, coronary artery disease, and ischemic nephropathy. Our
proposal provides a new paradigm whereby activation of the innate immune system via mitochondrial DNA
(mtDNA) leads to increased vasoconstriction, reduced vasodilation and vascular remodeling in hypertension.
Understanding this mechanism may assist in the development of new drugs that target the immune system to
treat vascular dysfunction and prevent the progression of hypertension. The research will be guided by the
novel hypothesis that in hypertension, exaggerated vascular and tissue cell death give rise to mtDNA that
trigger the innate immune response via Toll-like receptor 9 (TLR9) causing vascular inflammation,
vasoconstriction, endothelial dysfunction and vascular remodeling. A rat model of hypertension
[spontaneously hypertensive rat (SHR)] will be used and we will test our hypothesis by accomplishing three
specific aims: 1) test the hypothesis that pharmacological inhibition of cell necrosis attenuates the
development of vascular dysfunction in hypertension; 2) test the hypothesis that activation of TLR9 signaling
causes endothelial dysfunction, potentiates vasoconstriction and contributes to arterial stiffening; and 3) test
the hypothesis that mtDNA contributes to the development and maintenance of hypertension. The proposed
studies, integrating physiological, pharmacological, biochemical, molecular and cellular techniques, will help to
better understand the effects of blood pressure on vascular function, as well as the contribution of abnormal
TLR9 activation to vascular dysfunction characteristic of hypertension.
项目概要P1,网络
线粒体DNA激活Toll样受体9导致高血压血管损伤
高血压影响超过7500万美国成年人,通常在终末器官损伤中起主要作用。
常见于心血管疾病,包括中风、冠状动脉疾病和缺血性肾病。我们
一项提案提供了一种新的范例,通过线粒体DNA激活先天免疫系统,
线粒体DNA(mtDNA)的缺失导致高血压中血管收缩增加、血管舒张减少和血管重塑。
了解这种机制可能有助于开发针对免疫系统的新药,
治疗血管功能障碍,防止高血压的发展。这项研究将由
一种新的假说,即在高血压中,过度的血管和组织细胞死亡引起mtDNA,
通过Toll样受体9(TLR 9)触发先天免疫应答,引起血管炎症,
血管收缩、内皮功能障碍和血管重塑。高血压大鼠模型
[自发性高血压大鼠(SHR)]将被使用,我们将测试我们的假设,通过完成三个
具体目的:1)测试药理学抑制细胞坏死减弱细胞凋亡的假设,
高血压中血管功能障碍的发展; 2)测试TLR 9信号传导的激活
导致内皮功能障碍,增强血管收缩,并有助于动脉硬化;和3)测试
线粒体DNA与高血压的发展和维持有关的假说。拟议
综合生理学、药理学、生物化学、分子和细胞技术的研究将有助于
更好地了解血压对血管功能的影响,以及异常血压的贡献。
TLR 9活化对高血压特征性血管功能障碍的影响
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R Clinton Webb其他文献
Neurophysiological basis of penile erection
阴茎勃起的神经生理基础
- DOI:
10.1111/j.1745-7254.2007.00584.x - 发表时间:
2007-06-01 - 期刊:
- 影响因子:8.400
- 作者:
Fernanda B M Priviero;Romulo Leite;R Clinton Webb;Cleber E Teixeira - 通讯作者:
Cleber E Teixeira
Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?
对 COVID-19 和 ACEI/ARB 的回应:不相关?
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:3.2
- 作者:
E. Schiffrin;John M. Flack;S. Ito;P. Muntner;R Clinton Webb - 通讯作者:
R Clinton Webb
R Clinton Webb的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R Clinton Webb', 18)}}的其他基金
Damage-Associated Molecular Patterns in Hypertension
高血压损伤相关的分子模式
- 批准号:
9209298 - 财政年份:2017
- 资助金额:
$ 38万 - 项目类别:
TNF-alpha: a key player in erectile (dys)function
TNF-α:勃起(功能障碍)的关键因素
- 批准号:
7872961 - 财政年份:2009
- 资助金额:
$ 38万 - 项目类别:
TNF-alpha: a key player in erectile (dys)function
TNF-α:勃起(功能障碍)的关键因素
- 批准号:
8298246 - 财政年份:2009
- 资助金额:
$ 38万 - 项目类别:
TNF-alpha: a key player in erectile (dys)function
TNF-α:勃起(功能障碍)的关键因素
- 批准号:
7735745 - 财政年份:2009
- 资助金额:
$ 38万 - 项目类别:
TNF-alpha: a key player in erectile (dys)function
TNF-α:勃起(功能障碍)的关键因素
- 批准号:
8116051 - 财政年份:2009
- 资助金额:
$ 38万 - 项目类别:
Vascular RhoA/Rho-kinase Signaling in Angiotensin II-induced Hypertension
血管紧张素 II 诱导的高血压中的血管 RhoA/Rho 激酶信号转导
- 批准号:
7433779 - 财政年份:2007
- 资助金额:
$ 38万 - 项目类别:
Vascular Rho-kinase Signaling in Angiotensin II hyperten
血管紧张素 II 高血压中的血管 Rho 激酶信号转导
- 批准号:
7228247 - 财政年份:2006
- 资助金额:
$ 38万 - 项目类别:
Vascular Rho-kinase Signaling in Angiotensin II hyperten
血管紧张素 II 高血压中的血管 Rho 激酶信号转导
- 批准号:
7063186 - 财政年份:2005
- 资助金额:
$ 38万 - 项目类别:
Cytokines and angiotensin II-induced hypertension
细胞因子和血管紧张素 II 诱导的高血压
- 批准号:
7060929 - 财政年份:2004
- 资助金额:
$ 38万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 38万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)